Trial Profile
A prospective, double-masked, multicenter, study investigating the effect of latanoprost in patients with glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 10 Dec 2015 New trial record